Revolo Biotherapeutics Enters Manufacturing Agreement with CordenPharma to Scale Up and Manufacture ‘1104 for the Treatment of Eosinophilic Esophagitis and Allergic Disease
Agreement ensures supply to support clinical and commercial operationsNEW ORLEANS and LONDON, April 15, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics...